Department of Chemistry, Lund University, Lund, Sweden.
Department of Chemistry, Lund University, Lund, Sweden; Radcliffe Department of Medicine and Medical Research Council Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.
Biophys J. 2021 Nov 16;120(22):5032-5040. doi: 10.1016/j.bpj.2021.10.010. Epub 2021 Oct 13.
The two-dimensional (2D) affinity between protein molecules across contacting cells is a key parameter regulating and initiating several cellular processes. However, measuring 2D affinity can be challenging, and experimental data are limited. In addition, the obtained 2D affinities are typically averaged over the cell population. We here present a method to measure 2D affinity on single cells binding to polyhistidine-tagged fluorescent ligands anchored to a supported lipid bilayer (SLB). By decreasing the density of ligands in the SLB using imidazole, a new steady-state accumulation in the contact is obtained, and from this change, both the 2D affinity and the number of receptors on the cell can be determined. The method was validated on an SLB containing rat CD2 binding to the rat CD48 mutant T92A expressed on Jurkat T cells. The addition of imidazole did not influence the average 2D affinity (1/K), and the spread in affinities within the cell population was low, K = 4.9 ± 0.9 molecules/μm (mean ± SD), despite an order of magnitude spread in ligand accumulation because of differences in receptor density. It was also found that cell contact size increased both with ligand density and with the number of receptors per cell but that the contact size stayed approximately constant when lowering the ligand density, above a density of around 10 rat CD2 molecules/μm, after the contact first had formed, indicative of a heterogeneous process. In summary, this method not only allows for single-cell affinities to be measured, but it can also reduce measurement and analysis time and improve measurement accuracy. Because of the low spread in 2D K within the cell population, the analysis can further be restricted to the cells showing the strongest binding, paving the way for using this method to study weak binding events.
蛋白质分子在接触细胞之间的二维(2D)亲和力是调节和启动多个细胞过程的关键参数。然而,测量 2D 亲和力可能具有挑战性,并且实验数据有限。此外,获得的 2D 亲和力通常是细胞群体的平均值。在这里,我们介绍了一种在结合到固定在支持脂质双层(SLB)上的组氨酸标签荧光配体的单细胞上测量 2D 亲和力的方法。通过使用咪唑降低 SLB 中配体的密度,可以在接触中获得新的稳态积累,并且可以从这种变化中确定 2D 亲和力和细胞上的受体数量。该方法在含有大鼠 CD2 的 SLB 上进行了验证,该 SLB 与 Jurkat T 细胞上表达的大鼠 CD48 T92A 突变体结合。添加咪唑不会影响平均 2D 亲和力(1/K),并且细胞群体中亲和力的分散度较低,K = 4.9 ± 0.9 分子/μm(平均值 ± SD),尽管由于受体密度的差异,配体积累的数量相差一个数量级,但由于配体密度和每个细胞的受体数量增加,细胞接触面积增加,但在接触首先形成后,当降低配体密度时,接触面积保持大致恒定,这表明这是一个异质过程。总之,该方法不仅可以测量单细胞亲和力,还可以减少测量和分析时间并提高测量精度。由于细胞群体中 2D K 的分散度较低,因此可以进一步将分析限制在显示最强结合的细胞上,为使用该方法研究弱结合事件铺平了道路。